CD2 which is s a co-receptor expressed on T cells that plays a role in T-cell activation and adhesion [70] is also upregulated in PBMCs of CRC patients reflecting increased activation of, as well as exhausted or dysfunctional T cells. This evidence concerns the gene CD2 and colorectal carcinoma.